Olatec Therapeutics LLC Company
clinical stage biotech developing a new class of antiinflammatory therapeutics to address a broad spectrum of diseases by targeting NLRP3
Employee Number:
1-10
Headquarters:
New York, New York, United States
Technology:
Neurological Disorders
Estimated Revenue:
$1M to $10M
Industry:
PharmTech